31109379|t|Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human alpha-synuclein.
31109379|a|Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated alpha-synuclein are the signature neuropathological hallmark of multiple system atrophy (MSA). Native alpha-synuclein can adopt a prion conformation that self-propagates and spreads throughout the brain ultimately resulting in neurodegeneration. A growing body of evidence argues that, in addition to oligodendrocytes, astrocytes contain alpha-synuclein inclusions in MSA and other alpha-synucleinopathies at advanced stages of disease. To study the role of astrocytes in MSA, we added MSA brain homogenate to primary cultures of astrocytes from transgenic (Tg) mouse lines expressing human alpha-synuclein. Astrocytes from four Tg lines, expressing either wild-type or mutant (A53T or A30P) human alpha-synuclein, propagated and accumulated alpha-synuclein prions. Furthermore, we found that MSA-infected astrocytes formed two morphologically distinct alpha-synuclein inclusions: filamentous and granular. Both types of cytoplasmic inclusions shared several features characteristic of alpha-synuclein inclusions in synucleinopathies: hyperphosphorylation preceded by aggregation, ubiquitination, thioflavin S-positivity, and co-localization with p62. Our findings demonstrate that human alpha-synuclein forms distinct inclusion morphologies and propagates within cultured Tg astrocytes exposed to MSA prions, indicating that alpha-synuclein expression determines the tropism of inclusion formation in certain cells. Thus, our work may prove useful in elucidating the role of astrocytes in the pathogenic mechanisms that feature in neurodegeneration caused by MSA prions.
31109379	15	38	multiple system atrophy	Disease	MESH:D019578
31109379	92	96	mice	Species	10090
31109379	108	113	human	Species	9606
31109379	114	129	alpha-synuclein	Gene	6622
31109379	213	228	alpha-synuclein	Gene	6622
31109379	277	300	multiple system atrophy	Disease	MESH:D019578
31109379	302	305	MSA	Disease	MESH:D019578
31109379	315	330	alpha-synuclein	Gene	6622
31109379	440	457	neurodegeneration	Disease	MESH:D019636
31109379	551	566	alpha-synuclein	Gene	6622
31109379	581	584	MSA	Disease	MESH:D019578
31109379	595	618	alpha-synucleinopathies	Disease	MESH:D000080874
31109379	685	688	MSA	Disease	MESH:D019578
31109379	699	702	MSA	Disease	MESH:D019578
31109379	775	780	mouse	Species	10090
31109379	798	803	human	Species	9606
31109379	804	819	alpha-synuclein	Gene	6622
31109379	891	895	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
31109379	899	903	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:1;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:9606;CA#:257069
31109379	905	910	human	Species	9606
31109379	911	926	alpha-synuclein	Gene	6622
31109379	955	970	alpha-synuclein	Gene	6622
31109379	1006	1009	MSA	Disease	MESH:D019578
31109379	1066	1081	alpha-synuclein	Gene	6622
31109379	1199	1214	alpha-synuclein	Gene	6622
31109379	1229	1246	synucleinopathies	Disease	MESH:D000080874
31109379	1310	1322	thioflavin S	Chemical	MESH:C009462
31109379	1360	1363	p62	Gene	23636
31109379	1395	1400	human	Species	9606
31109379	1401	1416	alpha-synuclein	Gene	6622
31109379	1511	1521	MSA prions	Disease	MESH:D019578
31109379	1539	1554	alpha-synuclein	Gene	6622
31109379	1745	1762	neurodegeneration	Disease	MESH:D019636
31109379	1773	1783	MSA prions	Disease	MESH:D019578
31109379	Association	23636	6622
31109379	Association	MESH:D000080874	23636
31109379	Association	MESH:D019578	6622
31109379	Association	MESH:D019636	6622
31109379	Association	MESH:D000080874	6622

